Molina Healthcare, Inc. (MOH) SEC Filings & Earnings Calls

Marketplace revenue decline

“Marketplace premium revenue was $642 million for Q3 2026 vs $1,197 million for Q3 2025.”

Impairment risk from strategic shift

“we impaired the remaining intangible assets during the first quarter of 2026, which amounted to $93 million.” · word for word

Medical margin pressure

“Medical margin was $738 million for Q3 2026 vs $797 million for Q3 2025.”

Net income decline

“Net income was $38 million for Q3 2026 vs $79 million for Q3 2025.”

Elevated medical cost trend pressuring MCR and profitability

“Consolidated MCR 92.9% vs 92.6% YoY; pre-tax margin 0.5%”

Membership decline in Medicaid and Marketplace reducing premium revenue

“Premium revenue -4% YoY due to lower membership”

Florida Medicaid contract implementation and MAPD product exit expected to cause $1.50 and $1.00 per share losses in Q4 2026

“Loss of $1.50 per share due to Florida Medicaid contract; loss of $1.00 per share due to MAPD exit”

Securities class action lawsuit

“On October 3, 2025, a securities class action, captioned Hindlemann v. Molina Healthcare, Inc., et al., was filed... The Securities Action asserts violations of federal securities laws relating to the Company’s disclosures, including those involving earnings guidance.” · word for word

Medicaid rate pressure

“Medicaid, Medicare, or Marketplace capitation rates that are insufficient to fully cover our medical care costs and/or the rates of utilization and the health acuity status of our members.” · word for word

Marketplace risk adjustment uncertainty

“Marketplace risk adjustment payables amounted to $693 million and related receivables amounted to $128 million, for a net payable of $565 million.”

Marketplace segment underperforming due to risk adjustment and unfavorable acuity mix; guidance reduced by $1.50 per share.

“a $1.50 decrease related to Marketplace” · word for word

Florida Medicaid contract implementation in Q4 2026 expected to cause $1.50 per share loss.

“Full year guidance includes a loss of $1.50 per share due to the implementation of the new Florida Medicaid contract in the fourth quarter of 2026” · word for word

Traditional MAPD product exit for 2027 expected to cause $1.00 per share loss.

“a loss of $1.00 per share due to performance of the traditional MAPD product, which the Company previously announced it will exit for 2027.” · word for word

Potential governance uncertainty due to officer departure.

“Item 5.02 indicates departure of a director or principal officer.”

Securities Class Action Lawsuit

“On October 3, 2025, a putative securities class action ... asserts violations of federal securities laws relating to the Company's disclosures including those involving earnings guidance.” · word for word

Medicaid Rate Pressure

“budget pressures on state governments and states' efforts to reduce rates and limit rate increases to avoid budget deficits” · word for word

Medicare Advantage Regulatory Risk

“insufficient Medicare Advantage rate adjustments, new rules pertaining to Medicare Risk Adjustment Data Validation” · word for word

Medicare Advantage exit impairment and margin compression signal elevated earnings risk.

“$93M impairment for MA-PD exit; MCR up 190bps YoY; pre-tax margin down 320bps.”

Medicaid membership contraction and Virginia contract loss reduce revenue base.

“Premium revenue down 4% YoY; membership decline due to market contraction and contract expiration.”

Medical Cost Trend Spike

“Because of the medical cost trend spike we and all managed healthcare companies in our sector experienced in the second half of 2025, resulting in the lowering of our adjusted EPS guidance for 2026” · word for word

CEO Retention Risk

“The one-time special grant to our chief executive officer was made to strengthen his retention, who was then (and remains) eligible to invoke his retirement right under his employment agreement.” · word for word

Shareholder Dissatisfaction / Governance Risk

“At our 2025 annual stockholders’ meeting, we did not receive approval by the majority of our stockholders of our say-on-pay proposal, with only 40% of the votes cast voting to approve our say-on-pay proposal.” · word for word

OBBBA Medicaid Enrollment Reduction

“We currently estimate the reduction in enrollment will be in the range of 15% to 20% by 2029 on 1.2 million members in our Medicaid Expansion population.” · word for word

Elevated Medical Cost Trend

“Medical Care Ratio 91.7% (2025) vs 89.1% (2024).”

Marketplace Subsidy Expiration

“We expect our Marketplace enrollment to decrease to a total of approximately 220,000 members by the end of the year. This would represent an estimated Marketplace premium revenue decrease of approximately 50% in 2026.” · word for word

Medicare MAPD Exit

“In early February 2026, we determined that the MAPD product does not align with our strategic shift to focus exclusively on dual eligible members in Medicare and we intend to exit this product for 2027.” · word for word

Strategic exit from Medicare Advantage Prescription Drug product may reduce revenue but aligns with dual eligible focus.

“decision to exit the Medicare Advantage Prescription Drug product for 2027 as that product does not align with the Company’s strategic shift to focus exclusively on dual eligible members in Medicare” · word for word

Medicaid MCR elevated at 91.8% with continued high utilization; rate/trend imbalance expected to persist through 2026.

“The Company experienced medical cost pressure due to continued high levels of utilization.” · word for word

Medicare MCR 92.4% with higher utilization among high-acuity members; MAPD product underperformance leading to exit.

“Medicare MCR reflects higher utilization among high-acuity members, particularly for long-term services and supports and pharmacy.”

Marketplace MCR 90.6% with much higher levels of utilization relative to risk adjustment revenue.

Operating cash outflow of $535M in FY2025, driven by Medicaid risk corridor settlement and lower operating performance.

“Operating cash flow for the year ended December 31, 2025, was an outflow of $535 million.” · word for word

Increased debt levels may increase interest expense and leverage.

“Offering of notes and new credit agreement increase debt obligations.”

Increased debt service obligations with 6.500% coupon; refinancing risk if credit ratings deteriorate.

“6.500% senior notes due 2031” · word for word

Increased leverage from new debt issuance, though used to refinance existing debt.

“Proposed $750M senior notes offering to repay delayed draw term loans.”

Contract award subject to protest or legal challenge.

“Risks include successful protest or legal action by another bidder.”

Start date not yet determined; potential delay.

“The contract start date has not yet been determined.” · word for word